insights_auto
Why is AZN up 2,85%?
Dive Deeperchevron_right
AZN:NYSE
AstraZeneca
166,68 US$
arrow_upward
+2,85%(+4,62) 1D
166,68 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 15 ოქტ, 16:00:03 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AZN...
Open
167,69 US$
High
169,81 US$
Low
166,49 US$
Mkt. cap
261,56 მლრ.
Avg. vol.
2,93 მლნ.
Volume
4,40 მლნ.
Dividend
1,93%
Quarterly dividend
0,81 US$
Ex-dividend date
6 აგვ. 2026
P/E ratio
24,92
52-wk high
212,71 US$
52-wk low
80,48 US$
EPS
6,69 US$
Beta
0,30
Shares outstanding
1,55 მლრდ.
No. of employees
96 ათ.
Open
167,69 US$
High
169,81 US$
Low
166,49 US$
Mkt. cap
261,56 მლრ.
Avg. vol.
2,93 მლნ.
Volume
4,40 მლნ.
Dividend
1,93%
Quarterly dividend
0,81 US$
Ex-dividend date
6 აგვ. 2026
P/E ratio
24,92
52-wk high
212,71 US$
52-wk low
80,48 US$
EPS
6,69 US$
Beta
0,30
Shares outstanding
1,55 მლრდ.
No. of employees
96 ათ.
News stories
From web sources and news partners
Fox Business
·
1 საათის წინ
AstraZeneca, Insitro strike AI drug discovery deal
Yahoo Finance
·
3 საათის წინ
AstraZeneca (LSE:AZN) Enters AI Drug Discovery Partnership In MASH And Cardiomyopathies
Zacks
·
4 საათის წინ
Can Gilead's Deal With VIR Boost Its Oncology Pipeline and Growth?
TradingKey
·
6 საათის წინ
AstraZeneca PLC Stock (AZN) Moved Up by 3.55% on Oct 15: What Signal Does It Send?
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About AstraZeneca
CEOPascal Soriot
Employees96,1 ათ.
Founded6 აპრ. 1999
Headquartersკემბრიჯი, Cambridgeshire, გაერთიანებული სამეფო
SectorPharmaceutical industry
Websiteastrazeneca.com